ReCor Medical has announced major advances in its Paradise System for renal denervation (RDN), confirming its commitment to lead in the treatment of patients with resistant hypertension (HTN). The company announced that it has received ...
Tags: renal denervation system, health, HTN
ReCor Medical has commenced a post-market Achieve study of its Gen-2 Paradise system, designed for use in patients with resistant high blood pressure. Featuring an over-the-wire 6Fr device and faster procedures, the CE-marked minimally ...
Tags: minimally invasive ultrasound device, ReCor Medical, high blood pressure
ReCor Medical has presented six-month follow-up data of eight patients treated via renal denervation with the company's Paradise system. The CE-marked Paradise system for renal denervation is based on ultrasound, not radiofrequency, ...
Tags: ReCor Medical, renal denervation, resistant hypertension patients